Risk and Innovation

Stéphane emphasizes the importance of investing in foundational technology rather than just focusing on end products. He shares how Moderna's approach to calculated risk has set it apart in the pharma industry, enabling rapid development and deployment of impactful solutions like the COVID-19 vaccine. By fostering a culture that embraces risk, the company has positioned itself to innovate and respond effectively to urgent health challenges.